Elizabeth Fox
Impact in
Papers in
- Co-authors
- Frank M. BalisBrenda J. WeigelBrigitte C. WidemannSusan E. BatesPeter C. AdamsonSusan M. BlaneyCharles G. MinardStephan D. Voss
- Journals
- Journal of Clinical Oncology (70 papers)Pediatric Blood & Cancer (24 papers)Clinical Cancer Research (17 papers)Cancer Chemotherapy and Pharmacology (17 papers)The Oncologist (7 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Elizabeth Fox
213 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 129
- Neurology 1.7k
- Oncology 2.0k
- Genetics 589
- Cancer Research 651
- Pulmonary and Respiratory Medicine 1.4k
Countries citing papers authored by Elizabeth Fox
This map shows the geographic impact of Elizabeth Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Fox more than expected).
Fields of papers citing papers by Elizabeth Fox
This network shows the impact of papers produced by Elizabeth Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Fox. The network helps show where Elizabeth Fox may publish in the future.
Co-authors
The 25 scholars most cited alongside Elizabeth Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 43 | |
| 6 | 2021 | 61 | |
| 7 | 2021 | 23 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 39 | |
| 10 | 2020 | 30 | |
| 11 | 2019 | 48 | |
| 12 | 2019 | 79 | |
| 13 | 2019 | 52 | |
| 14 | 2018 | 14 | |
| 15 | 2017 | 20 | |
| 16 | 2015 | 13 | |
| 17 | 2013 | 110 | |
| 18 | 2012 | 90 | |
| 19 | 2010 | 41 | |
| 20 | In vitro cytotoxicity of ABT-751, a novel tubulin inhibitor, in pediatric solid tumor cell lines | 2006 | 2 |
About Elizabeth Fox
Elizabeth Fox is a scholar working on Neurology, Oncology, Genetics, Hematology and Pulmonary and Respiratory Medicine, having authored 220 papers that have together received 5.8k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (88 papers), Cancer therapeutics and mechanisms (37 papers), Glioma Diagnosis and Treatment (29 papers), Sarcoma Diagnosis and Treatment (26 papers), Lung Cancer Treatments and Mutations (18 papers), Cancer Treatment and Pharmacology (15 papers), Lung Cancer Research Studies (15 papers) and Neuroendocrine Tumor Research Advances (14 papers). The work is most often cited by research in Neurology (1.7k citations), Oncology (2.0k citations), Genetics (589 citations), Cancer Research (651 citations) and Pulmonary and Respiratory Medicine (1.4k citations). Elizabeth Fox has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Frank M. Balis, Brenda J. Weigel, Brigitte C. Widemann, Susan E. Bates, Peter C. Adamson, Susan M. Blaney, Charles G. Minard, Stephan D. Voss, Joel M. Reid and Stacey L. Berg. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.